BioTuesdays

Category - Feature

Feature

In conversation with Ron Babecoff

By Len Zehr As a co-founder of BiondVax Pharmaceuticals (TASE:BNDX), Ron Babecoff has led the Israeli developer of a universal flu vaccine since its inception in 2003. Prior to BiondVax, Dr. Babecoff was with Omrix...

October 14, 2014
Feature

How Itamar Medical’s PAT signal is improving health

By Len Zehr Using an unique and innovative technology known as peripheral arterial tone (PAT), Itamar Medical (TASE:ITMR) is detecting the functioning and health of arteries through a finger sensor for the diagnosis of...

October 7, 2014
Feature

In conversation with Pivotal Therapeutics

By Len Zehr BioTuesdays.com recently sat down with the management team at Pivotal Therapeutics (OTCQX:PVTTF; CSE:PVO) to discuss the company’s VASCAZEN product that addresses Omega-3 deficiency in cardiovascular disease...

September 30, 2014
Feature

Finding the origins of cancer with Rosetta Genomics

By Len Zehr Taking its name from the Rosetta Stone, which paved the way to decipher ancient Egyptian hieroglyphics, Rosetta Genomics (NASDAQ:ROSG) is unlocking the relevance of microRNA within the human genome to...

August 26, 2014
Feature

Titan implanting treatments for opioid dependence

By Len Zehr In the continuing struggle to circumvent abuse of drugs to treat opioid dependence and enhance compliance regimes for better outcomes, Titan Pharmaceuticals (OTCBB:TTNP) is leading the race with a matchstick...

August 19, 2014
Feature

In conversation with Jason Mitakidis

By Len Zehr As president and CEO of closely held Cyclica, Jason Mitakidis first became interested in computer simulation or, in silico, drug discovery while he was working as a bioinformatician at the Barcode...

August 5, 2014